World Journal of
Pharmaceutical and Life Sciences

PHARMACOLOGICAL SIGNIFICANCE OF WITHANIA SOMNIFERA IN INFLAMMATION-RELATED DISORDERS

Anjlee Yadav*, Vivek Gupta, Jitendra Kumar Malik, Gyan Singh, Yogesh Bhardwaj

ABSTRACT

Inflammation is a multifaceted biological response that underlies the progression of numerous acute and chronic diseases, including arthritis, cardiovascular disorders, diabetes, and neurodegenerative conditions. Despite the widespread use of conventional anti-inflammatory drugs, their prolonged administration is often associated with significant adverse effects, thereby necessitating the exploration of safer, plant-based therapeutic alternatives. Medicinal plants have emerged as promising candidates due to their multi-targeted actions, biocompatibility, and long-standing use in traditional medicine systems. Among these, Withania somnifera (Ashwagandha) has gained remarkable attention for its potent anti-inflammatory, antioxidant, and immunomodulatory properties. The therapeutic efficacy of Withania somnifera is largely attributed to its rich repertoire of bioactive phytoconstituents, including withanolides (notably withaferin A), alkaloids, and sitoindosides. These compounds exert significant pharmacological effects by modulating critical inflammatory pathways, such as inhibition of nuclear factor-kappa B (NF-κB), suppression of pro-inflammatory cytokines (TNF-α, IL-6), and downregulation of cyclooxygenase-2 (COX-2). Furthermore, its strong antioxidant potential plays a pivotal role in mitigating oxidative stress, thereby interrupting inflammation-driven cellular damage and disease progression. A substantial body of evidence from in vitro and in vivo studies highlights its efficacy in attenuating inflammatory responses; while emerging clinical investigations further support its therapeutic relevance in managing inflammation-associated disorders, including arthritis and metabolic syndromes. However, challenges such as lack of extract standardization, heterogeneity in experimental designs, and limited large-scale clinical validation persist. Future research should emphasize advanced formulation strategies, molecular mechanistic studies, and robust clinical trials to unlock its full therapeutic potential, ensuring safer, effective, and evidence-based integration into modern healthcare systems globally.

[Full Text Article]   [Download Certificate]